PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside

PD‐L1 in oral squamous cell carcinoma: A key biomarker from the laboratory to the bedside

Abstract Objectives and background: Oral squamous cell carcinoma (OSCC) is a highly malignant disease with an increasing incidence. The need to improve therapeutic strategies for patients affected by OSCC is an urgent challenge. Currently, the advent of immunotherapy represents an important step tow...

Full description

Bibliographic Details
Main Authors: Riccardo Nocini, Matteo Vianini, Ilaria Girolami, Luca Calabrese, Aldo Scarpa, Maurizio Martini, Patrizia Morbini, Stefano Marletta, Matteo Brunelli, Gabriele Molteni, Anil Parwani, Liron Pantanowitz, Albino Eccher
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Clinical and Experimental Dental Research
Subjects:
CD274
meta‐analysis
oral cancer
oral squamous cell carcinoma
PD‐L1
programmed death‐ligand 1
Online Access:https://doi.org/10.1002/cre2.590

Internet

https://doi.org/10.1002/cre2.590

Similar Items